Mearini E - Search Results

1

Influence of COVID-19 pandemic on stress levels of urologic patients.

Del Zingaro M, Cochetti G, Maiolino G, Stivalini D, Manfredini G, Tancredi A, Felici G, Ciarletti S, Gaudio G, Rossi de Vermandois JA, Mearini E. Del Zingaro M, et al. Among authors: mearini e. Open Med (Wars). 2021 Aug 25;16(1):1198-1205. doi: 10.1515/med-2021-0289. eCollection 2021. Open Med (Wars). 2021. PMID: 34514166 Free PMC article.

2

Color Doppler ultrasonography in the diagnosis of vascular abnormalities associated with ureteropelvic junction obstruction.

Mearini L, Rosi P, Zucchi A, Del Zingaro M, Mearini E, Costantini E. Mearini L, et al. Among authors: mearini e. J Endourol. 2003 Nov;17(9):745-50. doi: 10.1089/089277903770802290. J Endourol. 2003. PMID: 14642035

3

New therapeutic options for refractory neurogenic detrusor overactivity.

Giannantoni A, Mearini E, Di Stasi SM, Costantini E, Zucchi A, Mearini L, Fornetti P, Del Zingaro M, Navarra P, Porena M. Giannantoni A, et al. Among authors: mearini e, mearini l. Minerva Urol Nefrol. 2004 Mar;56(1):79-87. Minerva Urol Nefrol. 2004. PMID: 15195033 Free article. Clinical Trial.

4

Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.

Giannantoni A, Mearini E, Del Zingaro M, Santaniello F, Porena M. Giannantoni A, et al. Among authors: mearini e. BJU Int. 2008 Jul 25;102 Suppl 1:2-6. doi: 10.1111/j.1464-410X.2008.07820.x. BJU Int. 2008. PMID: 18665971 Review.

5

Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.

Giannantoni A, Mearini E, Del Zingaro M, Porena M. Giannantoni A, et al. Among authors: mearini e. Eur Urol. 2009 Mar;55(3):705-11. doi: 10.1016/j.eururo.2008.08.048. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18814955

6

The combination of urine DD3(PCA3) mRNA and PSA mRNA as molecular markers of prostate cancer.

Mearini E, Antognelli C, Del Buono C, Cochetti G, Giannantoni A, Nardelli E, Talesa VN. Mearini E, et al. Biomarkers. 2009 Jun;14(4):235-43. doi: 10.1080/13547500902807306. Biomarkers. 2009. PMID: 19489685

7

Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.

Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A. Giannantoni A, et al. Among authors: mearini e. J Urol. 2009 Oct;182(4):1453-7. doi: 10.1016/j.juro.2009.06.023. Epub 2009 Aug 15. J Urol. 2009. PMID: 19683298

8

Two-year efficacy and safety of botulinum a toxin intravesical injections in patients affected by refractory painful bladder syndrome.

Giannantoni A, Mearini E, Del Zingaro M, Proietti S, Porena M. Giannantoni A, et al. Among authors: mearini e. Curr Drug Deliv. 2010 Jan;7(1):1-4. doi: 10.2174/156720110790396463. Curr Drug Deliv. 2010. PMID: 19863481

9

Laparoscopic partial nephrectomy of thyroid cancer metastasis: case report and review of the literature.

Cochetti G, Puxeddu E, Zingaro MD, D'Amico F, Cottini E, Barillaro F, Mearini E. Cochetti G, et al. Among authors: mearini e. Onco Targets Ther. 2013 Apr 10;6:355-60. doi: 10.2147/OTT.S37402. Print 2013. Onco Targets Ther. 2013. PMID: 23596352 Free PMC article.

10

Circulating microRNAs and kallikreins before and after radical prostatectomy: are they really prostate cancer markers?

Egidi MG, Cochetti G, Serva MR, Guelfi G, Zampini D, Mechelli L, Mearini E. Egidi MG, et al. Among authors: mearini e. Biomed Res Int. 2013;2013:241780. doi: 10.1155/2013/241780. Epub 2013 Oct 9. Biomed Res Int. 2013. PMID: 24288670 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page